Natalizumab
Discovery
Development
Clinical
Filed
Commercialized
Therapeutic area
Therapeutic area
Multiple Sclerosis
Reference product
Reference product
Tysabri® (Biogen)
Commercial partners
Commercial partners
Sandoz
Status
Status
Commercialized
In-market brands
About this program
Natalizumab is a biosimilar developed to match Tysabri®, a reference biologic used in the treatment of Multiple Sclerosis.
Commercialization partners
Sandoz
EU
US
Germany
Let's build together.
If you want to explore what a partnership with us could look like, we're ready to talk.